欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Apoptosis  /  Bcl-2  /  AZD-5991

CAS No.: 2143061-81-6

AZD-5991 Catalog No. CSN21099

AZD5991 is a potent and selective Mcl-1 inhibitor for treatment of hematologic cancers (a phase I trial of Haematological malignancies).

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT03218683Relapsed or Refractory Hematol... more >>ogic Malignancies Non-Hodgkin Lymphoma Richter Syndrome Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma T-cell Lymphoma Multiple Myeloma Collapse <<Phase 1RecruitingOctober 23, 2019United States, California ... more >> Research Site Recruiting Orange, California, United States, 92868 United States, Colorado Research Site Recruiting Aurora, Colorado, United States, 80045 United States, District of Columbia Research Site Withdrawn Washington, District of Columbia, United States, 20007 United States, Georgia Research Site Recruiting Atlanta, Georgia, United States, 30322 United States, Massachusetts Research Site Recruiting Boston, Massachusetts, United States, 02215 United States, Missouri Research Site Recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Recruiting Hackensack, New Jersey, United States, 07601 United States, New York Research Site Recruiting New York, New York, United States, 10065 United States, Ohio Research Site Recruiting Columbus, Ohio, United States, 43210 United States, Oregon Research Site Not yet recruiting Portland, Oregon, United States, 97239 United States, Tennessee Research Site Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Research Site Recruiting Houston, Texas, United States, 77030 Research Site Not yet recruiting Houston, Texas, United States, 77030 Collapse <<

实验方案

技术信息

CAS号 2143061-81-6 储存条件
分子式 C35H34ClN5O3S2 运输 蓝冰
分子量 672.26 别名

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们